col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Public Library of Science: PLoS Pathogens
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―19 Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques Takushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, Trang Thi Thu Hau, Shigeyoshi Harada, Hiroshi Ishii, et al. (+17)
2 [GO] 2021―Jul―16 Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection Nidhi Shukla, Sarah M. Roelle, Vinicius G. Suzart, Anna M. Bruchez, Kenneth A. Matreyek, Jesse D. Bloom
3 [GO] 2021―Jul―16 SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence Sushma Boppana, Kai Qin, Jacob K. Files, Ronnie M. Russell, Regina Stoltz, Frederic Bibollet-Ruche, et al. (+5)
4 [GO] 2021―Jul―15 SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney Magen Ellen Francis, Una Goncin, Andrea Kroeker, Cynthia Swan, Robyn Ralph, Yao Lu, et al. (+7)
5 [GO] 2021―Jul―15 Intranasal gene therapy to prevent infection by SARS-CoV-2 variants Joshua J. Sims, Jenny A. Greig, Kristofer T. Michalson, Sharon Lian, R. Alexander Martino, Rosemary Meggersee, et al. (+10)
6 [GO] 2021―Jul―14 COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes Adrianne L. Jenner, Rosemary A. Aogo, Sofia Alfonso, Vivienne Crowe, Xiaoyan Deng, Amanda P. Smith, et al. (+5)
7 [GO] 2021―Jul―12 Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors Chaitra Prabhakara, Rashmi Godbole, Parijat Sil, Sowmya Jahnavi, Shah-e-Jahan Gulzar, Thomas S. van Zanten, et al. (+21)
8 [GO] 2021―Jul―06 Characterization of low-density granulocytes in COVID-19 Luz E. Cabrera, Pirkka T. Pekkarinen, Maria Alander, Kirsten H. A. Nowlan, Ngoc Anh Nguyen, Suvi Jokiranta, et al. (+10)
9 [GO] 2021―Jul―06 Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques Koen K. A. Van Rompay, Katherine J. Olstad, Rebecca L. Sammak, Joseph Dutra, Jennifer K. Watanabe, Jodie L. Usachenko, et al. (+24)
10 [GO] 2021―Jul―02 ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions Daniel J. Rawle, Thuy T. Le, Troy Dumenil, Kexin Yan, Bing Tang, Wilson Nguyen, et al. (+6)
11 [GO] 2021―Jun―28 The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity Carlos Ramirez Alvarez, Carmon Kee, Ashwini Kumar Sharma, Leonie Thomas, Florian I. Schmidt, Megan L. Stanifer, et al. (+3)
12 [GO] 2021―Jun―24 Dating first cases of COVID-19 David L. Roberts, Jeremy S. Rossman, Ivan Jarić, Benhur Lee
13 [GO] 2021―Jun―24 Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2 Min Zhao, Pei-Yi Su, Danielle A. Castro, Therese N. Tripler, Yingxia Hu, Matthew Cook, et al. (+7)
14 [GO] 2021―Jun―22 Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing Elizabeth Varghese, Samson Mathews Samuel, Alena Liskova, Peter Kubatka, Dietrich Büsselberg, Tom C. Hobman
15 [GO] 2021―Jun―17 Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection Liliana Echavarría-Consuegra, Georgia M. Cook, Idoia Busnadiego, Charlotte Lefèvre, Sarah Keep, Katherine Brown, et al. (+11)
16 [GO] 2021―Jun―09 Correction: Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? Ping Liu, Jing-Zhe Jiang, Xiu-Feng Wan, Yan Hua, Linmiao Li, Jiabin Zhou, et al. (+5)
17 [GO] 2021―Jun―07 Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan Yosuke Hirotsu, Masao Omata, Benhur Lee
18 [GO] 2021―May―27 TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2 Joseph D. Trimarco, Brook E. Heaton, Ryan R. Chaparian, Kaitlyn N. Burke, Raquel A. Binder, Gregory C. Gray, et al. (+4)
19 [GO] 2021―May―24 Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are features of alpacas resolving MERS-CoV infection Nigeer Te, Jordi Rodon, Maria Ballester, Mónica Pérez, Lola Pailler-García, Joaquim Segalés, et al. (+3)
20 [GO] 2021―May―20 Dispersal dynamics of SARS-CoV-2 lineages during the first epidemic wave in New York City Simon Dellicour, Samuel L. Hong, Bram Vrancken, Antoine Chaillon, Mandev S. Gill, Matthew T. Maurano, et al. (+8)
21 [GO] 2021―May―20 DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist Michel Thépaut, Joanna Luczkowiak, Corinne Vivès, Nuria Labiod, Isabelle Bally, Fátima Lasala, et al. (+9)
22 [GO] 2021―May―19 SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents Anna Fagre, Juliette Lewis, Miles Eckley, Shijun Zhan, Savannah M. Rocha, Nicole R. Sexton, et al. (+11)
23 [GO] 2021―May―18 Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity Sang Ho Park, Haley Siddiqi, Daniela V. Castro, Anna A. De Angelis, Aaron L. Oom, Charlotte A. Stoneham, et al. (+7)
24 [GO] 2021―Apr―29 Two courses of deconstructed coronavirus please Connor G. G. Bamford, Benhur Lee
25 [GO] 2021―Apr―26 Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread Jonathan W. Yewdell, Thomas E. Morrison
26 [GO] 2021―Apr―23 Palmitoylation of the envelope membrane proteins GP5 and M of porcine reproductive and respiratory syndrome virus is essential for virus growth Minze Zhang, Xiaoliang Han, Klaus Osterrieder, Michael Veit, Jens H. Kuhn
27 [GO] 2021―Apr―22 The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways Manon Laporte, Valerie Raeymaekers, Ria Van Berwaer, Julie Vandeput, Isabel Marchand-Casas, Hendrik-Jan Thibaut, et al. (+8)
28 [GO] 2021―Apr―21 Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization Alexandru A. Hennrich, Bevan Sawatsky, Rosalía Santos-Mandujano, Dominic H. Banda, Martina Oberhuber, Anika Schopf, et al. (+6)
29 [GO] 2021―Apr―20 Predicting the animal hosts of coronaviruses from compositional biases of spike protein and whole genome sequences through machine learning Liam Brierley, Anna Fowler, Adam S. Lauring
30 [GO] 2021―Apr―16 Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity Federica Bozzano, Chiara Dentone, Carola Perrone, Antonio Di Biagio, Daniela Fenoglio, Alessia Parodi, et al. (+14)
31 [GO] 2021―Apr―09 Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2 Huihui Mou, Brian D. Quinlan, Haiyong Peng, Guanqun Liu, Yan Guo, Shoujiao Peng, et al. (+13)
32 [GO] 2021―Apr―08 High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19 Sung Hee Ko, Elham Bayat Mokhtari, Prakriti Mudvari, Sydney Stein, Christopher D. Stringham, Danielle Wagner, et al. (+11)
33 [GO] 2021―Apr―08 A human coronavirus evolves antigenically to escape antibody immunity Rachel T. Eguia, Katharine H. D. Crawford, Terry Stevens-Ayers, Laurel Kelnhofer-Millevolte, Alexander L. Greninger, Janet A. Englund, et al. (+3)
34 [GO] 2021―Apr―07 Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts Andrew L. Valesano, Kalee E. Rumfelt, Derek E. Dimcheff, Christopher N. Blair, William J. Fitzsimmons, Joshua G. Petrie, et al. (+3)
35 [GO] 2021―Mar―29 Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19 Christophe Rodriguez, Nicolas de Prost, Slim Fourati, Claudie Lamoureux, Guillaume Gricourt, Melissa N’debi, et al. (+16)
36 [GO] 2021―Mar―26 Sex- and age-specific clinical and immunological features of coronavirus disease 2019 Shengwei Jin, Hui An, Tong Zhou, Ting Li, Mengzhen Xie, Saijing Chen, et al. (+6)
37 [GO] 2021―Mar―25 Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection Morgane Rolland, Peter B. Gilbert, Matthew J. Evans
38 [GO] 2021―Mar―25 Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model Drishya Kurup, Delphine C. Malherbe, Christoph Wirblich, Rachael Lambert, Adam J. Ronk, Leila Zabihi Diba, et al. (+3)
39 [GO] 2021―Mar―24 Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry Wenlin Ren, Yunkai Zhu, Yuyan Wang, Hongyang Shi, Yin Yu, Gaowei Hu, et al. (+15)
40 [GO] 2021―Mar―19 SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event Madlen Stange, Alfredo Mari, Tim Roloff, Helena MB Seth-Smith, Michael Schweitzer, Myrta Brunner, et al. (+17)
41 [GO] 2021―Mar―12 A novel cell culture system modeling the SARS-CoV-2 life cycle Xiaohui Ju, Yunkai Zhu, Yuyan Wang, Jingrui Li, Jiaxing Zhang, Mingli Gong, et al. (+8)
42 [GO] 2021―Mar―11 Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort Mokhtar R. Gomaa, Amira S. El Rifay, Mahmoud Shehata, Ahmed Kandeil, Mina Nabil Kamel, Mohamed A. Marouf, et al. (+15)
43 [GO] 2021―Mar―10 The pivot: Fighting Irish fighting COVID-19 Kasturi Haldar, Thomas E. Morrison
44 [GO] 2021―Mar―03 A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2 Hebang Yao, Hongmin Cai, Tingting Li, Bingjie Zhou, Wenming Qin, Dimitri Lavillette, et al. (+2)
45 [GO] 2021―Feb―26 Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication Bo Gao, Xiaoqian Gong, Shouguo Fang, Wenlian Weng, Huan Wang, Hongyan Chu, et al. (+10)
46 [GO] 2021―Feb―26 Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck Katarina M. Braun, Gage K. Moreno, Peter J. Halfmann, Emma B. Hodcroft, David A. Baker, Emma C. Boehm, et al. (+10)
47 [GO] 2021―Feb―26 Breadth and function of antibody response to acute SARS-CoV-2 infection in humans Kuan-Ying A. Huang, Tiong Kit Tan, Ting-Hua Chen, Chung-Guei Huang, Ruth Harvey, Saira Hussain, et al. (+20)
48 [GO] 2021―Feb―18 Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes Ilja L. Kruglikov, Philipp E. Scherer, Thomas E. Morrison
49 [GO] 2021―Feb―17 SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development Nicholas Murgolo, Alex G. Therien, Bonnie Howell, Daniel Klein, Kenneth Koeplinger, Linda A. Lieberman, et al. (+7)
50 [GO] 2021―Feb―11 Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors Michael Mor, Michal Werbner, Joel Alter, Modi Safra, Elad Chomsky, Jamie C. Lee, et al. (+23)
51 [GO] 2021―Feb―09 Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins Kim M. Bouwman, Ilhan Tomris, Hannah L. Turner, Roosmarijn van der Woude, Tatiana M. Shamorkina, Gerlof P. Bosman, et al. (+8)
52 [GO] 2021―Feb―01 Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab Gaia Meoni, Veronica Ghini, Laura Maggi, Alessia Vignoli, Alessio Mazzoni, Lorenzo Salvati, et al. (+13)
53 [GO] 2021―Jan―29 Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice Jessica B. Graham, Jessica L. Swarts, Sarah R. Leist, Alexandra Schäfer, Vineet D. Menachery, Lisa E. Gralinski, et al. (+10)
54 [GO] 2021―Jan―28 Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium Jessica K. Fiege, Joshua M. Thiede, Hezkiel Arya Nanda, William E. Matchett, Patrick J. Moore, Noe Rico Montanari, et al. (+9)
55 [GO] 2021―Jan―25 Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion Guido Papa, Donna L. Mallery, Anna Albecka, Lawrence G. Welch, Jérôme Cattin-Ortolá, Jakub Luptak, et al. (+7)
56 [GO] 2021―Jan―21 SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells Michihito Sasaki, Kentaro Uemura, Akihiko Sato, Shinsuke Toba, Takao Sanaki, Katsumi Maenaka, et al. (+4)
57 [GO] 2021―Jan―19 K18-hACE2 mice develop respiratory disease resembling severe COVID-19 Claude Kwe Yinda, Julia R. Port, Trenton Bushmaker, Irene Offei Owusu, Jyothi N. Purushotham, Victoria A. Avanzato, et al. (+13)
58 [GO] 2021―Jan―19 The coronavirus proofreading exoribonuclease mediates extensive viral recombination Jennifer Gribble, Laura J. Stevens, Maria L. Agostini, Jordan Anderson-Daniels, James D. Chappell, Xiaotao Lu, et al. (+4)
59 [GO] 2021―Jan―19 Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2 Tianling Ou, Huihui Mou, Lizhou Zhang, Amrita Ojha, Hyeryun Choe, Michael Farzan, Benhur Lee
60 [GO] 2021―Jan―14 Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina Diego S. Ojeda, María Mora Gonzalez Lopez Ledesma, Horacio M. Pallarés, Guadalupe S. Costa Navarro, Lautaro Sanchez, Beatriz Perazzi, et al. (+11)
61 [GO] 2021―Jan―04 The role of Neuropilin-1 in COVID-19 Bindu S. Mayi, Jillian A. Leibowitz, Arden T. Woods, Katherine A. Ammon, Alphonse E. Liu, Aarti Raja, Rachel Fearns
62 [GO] 2020―Dec―16 mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2 Mariah Hassert, Elizabeth Geerling, E. Taylor Stone, Tara L. Steffen, Madi S. Feldman, Alexandria L. Dickson, et al. (+5)
63 [GO] 2020―Dec―16 Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators Suelen da Silva Gomes Dias, Vinicius Cardoso Soares, André C. Ferreira, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Jairo R. Temerozo, et al. (+17)
64 [GO] 2020―Dec―11 Disentangling the dynamical underpinnings of differences in SARS-CoV-2 pathology using within-host ecological models C. Jessica E. Metcalf, Bryan T. Grenfell, Andrea L. Graham, Seema Lakdawala
65 [GO] 2020―Dec―10 The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans Katarzyna Pancer, Aleksandra Milewska, Katarzyna Owczarek, Agnieszka Dabrowska, Michal Kowalski, Paweł Łabaj, et al. (+4)
66 [GO] 2020―Dec―07 Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles Akshamal M. Gamage, Kai Sen Tan, Wharton O. Y. Chan, Jing Liu, Chee Wah Tan, Yew Kwang Ong, et al. (+6)
67 [GO] 2020―Dec―07 SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells Tapas Patra, Keith Meyer, Lizzie Geerling, T. Scott Isbell, Daniel F. Hoft, James Brien, et al. (+4)
68 [GO] 2020―Dec―04 A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody Nicholas C. Wu, Meng Yuan, Sandhya Bangaru, Deli Huang, Xueyong Zhu, Chang-Chun D. Lee, et al. (+8)
69 [GO] 2020―Dec―02 Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein Dhurvas Chandrasekaran Dinesh, Dominika Chalupska, Jan Silhan, Eliska Koutna, Radim Nencka, Vaclav Veverka, et al. (+2)
70 [GO] 2020―Nov―30 Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection Jayasri Das Sarma, Amy Burrows, Patricia Rayman, Mi-Hyun Hwang, Soumya Kundu, Nikhil Sharma, et al. (+3)
71 [GO] 2020―Nov―12 Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression Huiwen Zheng, Heng Li, Lei Guo, Yan Liang, Jing Li, Xi Wang, et al. (+25)
72 [GO] 2020―Nov―02 The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors Anja Pišlar, Ana Mitrović, Jerica Sabotič, Urša Pečar Fonović, Milica Perišić Nanut, Tanja Jakoš, et al. (+3)
73 [GO] 2020―Oct―30 On the whereabouts of SARS-CoV-2 in the human body: A systematic review Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, Sarah Gerlo, Linos Vandekerckhove, Craig B. Wilen
74 [GO] 2020―Oct―29 “Trained immunity” from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes Samer Singh, Rajendra Prakash Maurya, Rakesh K. Singh, Thomas E. Morrison
75 [GO] 2020―Oct―28 Rapid deployment of SARS-CoV-2 testing: The CLIAHUB Emily D. Crawford, Irene Acosta, Vida Ahyong, Erika C. Anderson, Shaun Arevalo, Daniel Asarnow, et al. (+181)
76 [GO] 2020―Oct―09 Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19 Cormac M. Kinsella, Pauline Dianne Santos, Ignacio Postigo-Hidalgo, Alba Folgueiras-González, Tim Casper Passchier, Kevin P. Szillat, et al. (+4)
77 [GO] 2020―Sep―30 Translational Research in the Time of COVID-19-Dissolving Boundaries Jonathan D. Edgeworth, Rahul Batra, Gaia Nebbia, Karen Bisnauthsing, Eithne MacMahon, Malur Sudhanva, et al. (+13)
78 [GO] 2020―Sep―24 Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings Suzanne Pickering, Gilberto Betancor, Rui Pedro Galão, Blair Merrick, Adrian W. Signell, Harry D. Wilson, et al. (+26)
79 [GO] 2020―Sep―18 Exploring links between vitamin D deficiency and COVID-19 Mradul Mohan, Jerin Jose Cherian, Amit Sharma, Anuradha Chowdhary
80 [GO] 2020―Sep―18 SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts Amy L. Hartman, Sham Nambulli, Cynthia M. McMillen, Alexander G. White, Natasha L. Tilston-Lunel, Joseph R. Albe, et al. (+19)
81 [GO] 2020―Sep―10 A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients Yuxin Chen, Xin Tong, Yang Li, Bin Gu, Jiawei Yan, Yong Liu, et al. (+4)
82 [GO] 2020―Sep―09 Can data from paediatric cohorts solve the COVID-19 puzzle? Lien Anh Ha Do, Jeremy Anderson, Edward Kim Mulholland, Paul V. Licciardi, Carolyn B. Coyne
83 [GO] 2020―Sep―03 Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: A case study of bats Kevin J. Olival, Paul M. Cryan, Brian R. Amman, Ralph S. Baric, David S. Blehert, Cara E. Brook, et al. (+26)
84 [GO] 2020―Aug―27 COVID-19 real-world data for the US and lessons to reopen business Pascal J. Goldschmidt-Clermont, Anuradha Chowdhary
85 [GO] 2020―Aug―26 Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020 Cordelia Manickam, Sho Sugawara, R. Keith Reeves, Tom C. Hobman
86 [GO] 2020―Aug―21 COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2 Anshumali Mittal, Kavyashree Manjunath, Rajesh Kumar Ranjan, Sandeep Kaushik, Sujeet Kumar, Vikash Verma, Tom C. Hobman
87 [GO] 2020―Aug―12 Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease Daniel Montelongo-Jauregui, Taissa Vila, Ahmed S. Sultan, Mary Ann Jabra-Rizk, Rebecca Ellis Dutch
88 [GO] 2020―Aug―11 Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza Claire Scott, Jayakanth Kankanala, Toshana L. Foster, Daniel H. Goldhill, Peng Bao, Katie Simmons, et al. (+18)
89 [GO] 2020―Jul―29 Interplay between SARS-CoV-2 and the type I interferon response Margarida Sa Ribero, Nolwenn Jouvenet, Marlène Dreux, Sébastien Nisole, Kenneth Stapleford
90 [GO] 2020―Jun―22 Biological sex impacts COVID-19 outcomes Sabra L. Klein, Santosh Dhakal, Rebecca L. Ursin, Sharvari Deshpande, Kathryn Sandberg, Franck Mauvais-Jarvis, Carolyn B. Coyne
91 [GO] 2020―Jun―18 A growing pandemic: A review of Nosema parasites in globally distributed domesticated and native bees Arthur C. Grupe, C. Alisha Quandt, Anuradha Chowdhary
92 [GO] 2020―Jun―04 In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction Sandra Silva-Arrieta, Philip J. R. Goulder, Christian Brander, Kasturi Haldar
93 [GO] 2020―May―22 The hallmarks of COVID-19 disease Daolin Tang, Paul Comish, Rui Kang, Tom C. Hobman
94 [GO] 2020―May―21 Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2 Adrien Breiman, Nathalie Ruvën-Clouet, Jacques Le Pendu, Carolyn B. Coyne
95 [GO] 2020―May―14 Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? Ping Liu, Jing-Zhe Jiang, Xiu-Feng Wan, Yan Hua, Linmiao Li, Jiabin Zhou, et al. (+6)
96 [GO] 2020―Apr―28 Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients Yifan Meng, Ping Wu, Wanrong Lu, Kui Liu, Ke Ma, Liang Huang, et al. (+8)
97 [GO] 2020―Mar―19 When Pigs Fly: Pandemic influenza enters the 21st century Nídia S. Trovão, Martha I. Nelson, Katherine R. Spindler
98 [GO] 2020―Mar―09 Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry Jian Shang, Yushun Wan, Chang Liu, Boyd Yount, Kendra Gully, Yang Yang, et al. (+5)
99 [GO] 2019―Dec―19 The pandemic Escherichia coli sequence type 131 strain is acquired even in the absence of antibiotic exposure Grant R. Whitmer, Ganga Moorthy, Mehreen Arshad, John M. Leong


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.017 sec